Biomarkers for immune checkpoint inhibitor response in NSCLC: current developments and applicability

K Tostes, AP Siqueira, RM Reis, LF Leal… - International Journal of …, 2023 - mdpi.com
Lung cancer has the highest mortality rate among all cancer types, resulting in over 1.8
million deaths annually. Immunotherapy utilizing immune checkpoint inhibitors (ICIs) has …

Gene expressions and high lymphocyte count may predict durable clinical benefits in patients with advanced non-small-cell lung cancer treated with immune …

MT Mouritzen, M Ladekarl, H Hager, TB Mattesen… - Cancers, 2023 - mdpi.com
Simple Summary Despite the promising results not all patients with advanced non-small cell
lung cancer benefit from immunotherapy. Immunotherapy may cause severe adverse …

An analysis of JADE2 in non-small cell lung cancer (NSCLC)

C Murphy, G Gornés Pons, A Keogh, L Ryan… - Biomedicines, 2023 - mdpi.com
The JADE family comprises three members encoded by individual genes and roles for these
proteins have been identified in chromatin remodeling, cell cycle progression, cell …

Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19

NW Kam, CY Lau, CM Che, VHF Lee - Cancers, 2023 - mdpi.com
Simple Summary One of the questions that experts are trying to answer about COVID-19 is
whether it will have a positive or negative effect on cancer. It is important to consider the …

Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage

F Ionescu, J Nguyen, CM Segura, M Paravathaneni… - Cancers, 2024 - mdpi.com
Simple Summary Penile cancer is a rare and aggressive disease. Current treatment options
when the cancer is locally advanced are suboptimal and potentially mutilating. Insight into …